Zepbound (Tirzepatide) 4 doses - Médetone

Zepbound (Tirzepatīds) 4 devas

€999,00

Weight management for high BMI

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.

Kas iekļauts cenā?

Ietver medicīnisku konsultāciju un recepti, ja tas ir klīniski piemēroti, ar jūsu ārstēšanu, kas tiek izsniegta un piegādāta uz jūsu mājām. Tiek nodrošinātas regulāras klīniskās pārbaudes un uzraudzība, lai atbalstītu jūsu ārstēšanu un sekotu progresam.

Garantijas

Tas paša dienā nosūtīšana apstiprinātām pasūtījumiem
Diskrēta, konfidenciāla piegāde
Ekspertu klīniskā vadība
Ātra klientu atbalsta reakcija

Nepieciešama derīga personu apliecinoša dokumenta uzrādīšana

Identitātes pārbaude ir nepieciešama pirms receptes izsniegšanas un šī medikamenta izsniegšanas. Pēc pasūtījuma veikšanas jums tiks lūgts uzrādīt derīgu personu apliecinošu dokumentu. Pieņemtie dokumentu veidi ir nacionālā ID karte, pase vai vadītāja apliecība.

Stiprums: 2.5 mg

2.5 mg
5 mg
7.5 mg
10 mg
12.5 mg
15 mg

Preču varianti

Our customers say Excellent Rated 4.7 Trustpilot Trustpilot

Zepbound Tirzepatide Weight Loss Injections

Ātra kopsavilkums

Zāļu veids

Dual GIP and GLP-1 receptor agonist.

Darbojas, izmantojot

Eligible for patients with a BMI over 30, or over 27 if they have at least one comorbidity.

Aktīvā viela

Tirzepatide

Efektīvs laikā

Within a few weeks.

Generisks?

No

Blakusparādības

Nausea, vomiting, diarrhea, decreased hunger, stomach pain, and constipation.

How it works

Clinician-led care, designed to be simple from start to finish.

1

Step 1

Check eligibility

Answer a short 2-minute questionnaire so we can understand your goals and medical history.

2

Step 2

Doctor approval

If eligible, one of our doctors issues your free prescription within 24 hours.

3

Step 3

Fast delivery, ongoing support

Next-day delivery across the EU, with support at every step of your treatment.

Zāļu informācija

Apraksts

Zepbound (tirzepatīds) ir vienreiz nedēļā lietojams zemādas GLP-1 receptoru agonists un GIP receptoru agonists, kas paredzēts hroniskai svara kontrolei pieaugušajiem ar aptaukošanos (ĶMI ≥ 30 kg/m²) vai lieko svaru (ĶMI ≥ 27 kg/m²) ar vismaz vienu svaru saistītu blakus slimību, piemēram, hipertensiju, 2. tipa cukura diabētu vai dislipidēmiju. Klīniskie pierādījumi rāda efektivitāti ķermeņa svara samazināšanā un kardiometabolisko parametru uzlabošanā, kombinējot ar dzīvesveida izmaiņām, tostarp kaloriju ierobežošanu un fiziskās aktivitātes palielināšanu. Zepbound ir parādījis potenciālu labumu apnojas-hipopnojas indeksa smaguma samazināšanā pacientiem ar vidēji smagu līdz smagu obstruktīvu miega apnoju un vienlaicīgu aptaukošanos. Kontrindikācijas ietver vienlaicīgu lietošanu ar citām tirzepatīdu saturošām formulām vai GLP-1 receptoru agonistu medikamentiem. Pediatriska drošība un efektivitāte nav noteikta. Ārstēšanu jāuzsāk un jāuzrauga kvalificētam veselības aprūpes speciālistam. Šis produkts ir paredzēts tikai ar recepti.

Lietošanas norādījumi

To use Zepbound effectively, start with the prescribed dose, injecting once a week on the same day. Administer injections in the abdomen, thigh, or upper arm, rotating sites to avoid irritation. Before injecting, clean your hands and the injection area. Let refrigerated medication warm slightly for comfort. Use clean techniques for needle attachment and injection, disposing of sharps properly. Store the medication in the fridge or briefly at room temperature as allowed. If a dose is missed, take it soon if within a few days; otherwise, skip it and never double dose. Regularly consult with your healthcare provider to adjust doses and discuss any side effects. Always follow your healthcare provider's detailed instructions.

Sastāvdaļas

Tirzepatide, the active substance in Zepbound, works by mimicking the actions of natural hormones in the body that regulate blood sugar and appetite. As a dual GIP (Glucose-dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-like Peptide-1) receptor agonist, it enhances insulin secretion in response to high blood sugar levels, slows down gastric emptying, and reduces appetite and food intake, leading to improved glycemic control and weight loss in adults with type 2 diabetes mellitus.

Blakusparādības

Gastrointestinal issues (nausea, vomiting, diarrhea, constipation), potential hypoglycemia (especially when used with other diabetes medications), injection site reactions, and possibly others depending on the individual's health condition and other medications being taken.

Brīdinājumi

When using Zepbound (tirzepatide), important precautions include being vigilant for severe abdominal pain indicative of pancreatitis, monitoring blood sugar levels due to the risk of hypoglycemia when combined with other diabetes medications, reporting any changes in urination that could signal kidney issues, and seeking immediate medical attention for persistent digestive problems like vomiting or diarrhea. It's also crucial to inform your doctor of any personal or family history of thyroid cancer, given studies in rodents linking Zepbound-like medications to thyroid issues. Be alert for signs of allergic reactions, and if you're pregnant or breastfeeding, consult with your healthcare provider about potential risks.

Jūsu stāsti, mūsu lepnums

Biežāk uzdotie jautājumi

How quickly does Zepbound start to work?

The onset of Zepbound's effects can vary, but patients may begin to see improvements in their blood sugar levels and weight within a few weeks of starting treatment. Continuous use in conjunction with diet and exercise enhances its efficacy.

Do I need a prescription for Zepbound?

Yes, Zepbound is a prescription medication. You will need to consult a healthcare provider to determine if it's appropriate for your condition and to receive a prescription. Using our online consultation service will enable you to answer a short questionnaire that would be used by one of our clinical prescribers to determine your eligibility for the treatment and approve or decline and refund your order.

How is Zepbound administered?

Zepbound is administered as a subcutaneous injection once a week. It can be injected into the abdomen, thigh, or upper arm, with the site of injection rotated each week to minimise the risk of skin irritation.

How should Zepbound be stored?

Zepbound should be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Keep the pen in its original packaging to protect from light. Once in use, it may be kept at room temperature for 30 days.

What is the difference between Wegovy and Zepbound?

Wegovy and Zepbound are both injectable medications used primarily for weight management in adults, but they differ in their active ingredients and mechanisms of action.

Wegovy:

Active Ingredient: Semaglutide.
Mechanism of Action: Wegovy functions as a GLP-1 receptor agonist, mimicking the action of the glucagon-like peptide-1 hormone which regulates appetite and calorie intake. It enhances feelings of fullness and reduces hunger, leading to a reduction in food intake.
Usage: Approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia.

Zepbound:

Active Ingredient: Tirzepatide.
Mechanism of Action: Zepbound is unique in that it acts as both a GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist. This dual action not only helps in reducing appetite and food intake like GLP-1 agonists but also enhances insulin secretion in a glucose-dependent manner and possibly affects fat metabolism.
Usage: Initially approved for the treatment of type 2 diabetes, with promising results in significant weight reduction, leading to its approval for use in obesity management as well.

While both medications are part of a broader category of drugs used for metabolic management, the dual mechanism of Zepbound may offer broader metabolic effects compared to Wegovy. Both have shown effectiveness in weight loss and improvements in various metabolic parameters in clinical trials, but the choice between them may depend on individual health profiles, specific medical conditions, and healthcare provider recommendations.

Pārbaudīt atbilstību